Oxygerolan 40 mg - Retardtabletten

Recall | Medicines | 27/08/2020

The marketing authorisation holder informed its customers on August 27, 2020 that the specified active ingredient content cannot be guaranteed in each individual tablet.

Therefore, the concerned batch will be recalled.

Name of the medicinal product Oxygerolan 40 mg - Retardtabletten
Marketing authorisation number(s) 1-29622
CIP code 3775492
Marketing authorisation holder G.L. Pharma GmbH
Batch number(s) 9F119A
Classification of the recall 2
Depth of recall Pharmacies
BASG reference number INS-640.001-3297

Further inquiry note